Korro Bio, Inc. (KRRO)
NASDAQ: KRRO · Real-Time Price · USD
12.80
-0.04 (-0.31%)
At close: Apr 28, 2026, 4:00 PM EDT
13.05
+0.25 (1.95%)
After-hours: Apr 28, 2026, 4:47 PM EDT
Korro Bio Market Cap
Korro Bio has a market cap or net worth of $184.61 million as of April 28, 2026. Its market cap has increased by 51.60% in one year.
Market Cap
184.61M
Enterprise Value
142.91M
1-Year Change
51.60%
Ranking
Category
Stock Price
$12.80
Market Cap Chart
Since November 6, 2023, Korro Bio's market cap has increased from $123.80M to $184.61M, an increase of 49.12%. That is a compound annual growth rate of 17.53%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Apr 27, 2026 | 185.19M | 145.50% |
| Dec 31, 2025 | 75.43M | -78.85% |
| Dec 31, 2024 | 356.65M | -6.96% |
| Dec 29, 2023 | 383.31M | 209.63% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Context Therapeutics | 203.51M |
| MacroGenics | 202.12M |
| Whitehawk Therapeutics | 198.70M |
| Karyopharm Therapeutics | 198.38M |
| Cartesian Therapeutics | 189.27M |
| Canton Strategic Holdings | 189.23M |
| Unicycive Therapeutics | 185.75M |
| Acumen Pharmaceuticals | 182.70M |